Please replay one paragraph for each classmate (half page for each one) Classmat

By
Responsive Centered Red Button

Need Help with this Question or something similar to this? We got you! Just fill out the order form (follow the link below), and your paper will be assigned to an expert to help you ASAP.

Order Form

Please replay one paragraph for each classmate (half page for each one)
Classmate1 (Yda) Clinical Care or Systems of Service Delivery
Inpatient Psychiatry
Service
Inpatient Psychiatry
Service is one significant area of clinical practice where interest groups may
attempt to bring change in clinical care regarding service delivery. For a long
time, there have been complaints that inpatient patients are not given the best
clinical care in treating their mental health challenges (Wykes et al., 2018).
Longer admission to those who are involuntarily admitted has been blamed on the
ground that there is not adequate staff training. In turn, patients with
psychiatric issues have had to withstand lack of attention, poor clinical
set-ups, and lack of follow-up during treatment, and worse still, there are
wrongful diagnoses.
To solve the
challenges in the inpatient Psychiatric Service, current game-changing research
findings have been put out and received much attention from the public.
Stakeholders and shareholders of the healthcare sector have praised the
findings that there is a lack of trained staff who can deal with new mental
health challenges (Wykes et al., 2018). Besides, the research has also laid it
bare that the medical personnel are also experiencing mental health
difficulties, so they must be attended to before treating patients. Groups that
may be interested in the findings are; Psychiatrists, Psychologists, therapists,
and counselors who deal with patients’ mental problems.
The likely reaction tothe new research is that they may be relieved as they will now get to know theneed to be well trained. However, the finding may surprise the stakeholders as some of them are well trained, but quacks in the healthcare industry may have made the entire profession receive blame from the public (Wykes et al., 2018). Qualified psychiatrists and other professionals who treat mental health problems may ask for new vetting of caregivers in the entire fraternity to flush out those who do not follow professionalism and medical ethics.
Classmate 2 (Jea)
If, in most developed
countries health care is considered as a right where governments greatly
control health care, in the United States (US) a more business approach is
followed. In the US health care is viewed as a commodity that is influenced by
corporate governance and finance. Although the federal government finance
health Care for the elderly, the disabled and the very poor through Medicare
and Medicaid, for the most part, medical care and clinical practice are funded
and delivered in the US by private medical organization like HMOs, PPOs, etc.
These entities dictate the way health services are delivered in the US from the
micromanagement of clinical decisions to the type of relationship healthcare
providers have with their patients. With this system in place the
pharmaceutical industry positioned themselves as one of the most influential
groups that profit and bring about change in clinical care or systems of
service delivery.
Continuous progress in
clinical practice, health care and medicine go hand by hand with the
advancement of the pharmaceutical industry (so called Big Pharma) and the
constant appearance of new drugs. Although for the most past it is beneficial,
this relation can sometimes be detrimental to the patients, the health care
providers and to society at large. Big Pharma is very aggressive with their
marketing techniques and campaigns, and their lobbying activities. As a
marketing tool, representatives of the industry begin to make contact with
medical and certain health care students while they are still in school.
Although this is an acceptable practice, they offer physician and other health
care providers gifts, and invite them to events financed by a pharmaceutical
company in order to influence their clinical decisions. This practice creates
the conflict between health benefits and commercial profits. Through their
lobbying activities the Pharm industry is so powerful that they were able to
influence the passage of Medicare part D in 2006 where they set drugs price,
even the government could not negotiate them down until the Build Back Better
Act (BBBA) last November (Cubanski, 2021).
The Pharm industry is
reported having a net worth of nearly 1.3 trillion dollars in 2019 (Barton,
2020). Increasingly, their goal is to sell product to clients rather than
provide care to patients. This type of vigorous marketing really affects
quality of care, clinical practice and systems of service delivery. However,
promotional influences on drug prescribing and use are a problem because they
can lead to inappropriate therapeutic choices. This can occur if a drug is used
when the patient does not need it, if it is not used correctly, or whether it
is more expensive than equivalent alternatives. Promotional influences can also
be a problem for the medical and health care profession if they alter public
perception and lead to a loss of trust.

How to create Testimonial Carousel using Bootstrap5

Clients' Reviews about Our Services